Verista Inc.

Verista Inc. , based in the US, provides transformative solutions for the life sciences sector, emphasizing quality and compliance to ensure regulatory adherence and operational efficiency. Founded in 2020 in Fishers, US, Verista Inc. specializes in delivering services for the life sciences industry, including quality assurance and compliance.

The company has completed three deals, with its most recent deal occurring on March 1, 2022. The current CEOs are Manish Soman and Naomi Rule. Verista specializes in providing comprehensive solutions tailored for the life sciences sector, focusing primarily on quality and compliance throughout the product lifecycle. Their core offerings include computer system validation, commissioning, qualification, and automation solutions, alongside packaging, serialization, and machine vision technologies.

These services are designed to enhance operational efficiency, ensure regulatory compliance, and maintain product integrity, thereby addressing critical industry challenges such as data integrity and FDA verification. Verista serves a diverse clientele that includes top-tier pharmaceutical companies, biotech firms, and medical device manufacturers, with a market presence in North America, Europe, and select regions in Asia. Their solutions are utilized by quality assurance teams and operational managers who seek to streamline processes and mitigate risks associated with product recalls and regulatory audits. Verista's revenue model revolves around providing specialized services that are pivotal in the life sciences domain.

Transactions typically occur through direct partnerships with clients, wherein services are rendered on a project basis or through long-term contracts. The structure includes both B2B engagements, where services are tailored to meet the specific needs of large pharmaceutical and biotech organizations, and consultative agreements that support ongoing quality and compliance initiatives. While specific pricing details for individual services are proprietary, the service offerings encompass flagship capabilities such as regulatory compliance support and transformational services aimed at program and project management. The combination of these offerings enables Verista to establish a stable revenue stream while positioning itself as a trusted partner in the increasingly regulated life sciences industry.

Verista is focused on expanding its service offerings and market presence. The company is in the process of designing new solutions aimed at enhancing regulatory compliance and operational efficiencies, with anticipated launches scheduled for late 2023. Plans for geographic expansion include targeting markets in Asia and Europe by 2024. The recent funding secured on March 1, 2022, will be utilized to support these initiatives, strengthening Verista's operational capabilities and facilitating entry into these new markets.